Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar 2;16(1):89.
doi: 10.1186/s13256-022-03307-9.

Intermediary inflammatory reaction after micropulse cyclophotocoagulation diode therapy: a case report

Gaëtane Ghion  1 , Alexandra Singh  2 , Sayeh Pourjavan  2   3
Affiliations
Case Reports

Intermediary inflammatory reaction after micropulse cyclophotocoagulation diode therapy: a case report

Gaëtane Ghion et al. J Med Case Rep. .

Abstract

Introduction: Of the many types of laser cyclophotocoagulation procedures, micropulse cyclophotocoagulation diode is praised as a noninvasive, safe, and effective procedure with few complications. In this case report, we describe a rare complication that, to the best of our knowledge, has not been previously reported.

Case report: We report on the case of a 66-year-old African man with a history of end-stage primary open-angle glaucoma. One week after undergoing micropulse cyclophotocoagulation diode therapy in both eyes, he developed severe intermediary inflammation in one eye, associated with decreased visual acuity. The intraocular pressure had significantly decreased after the procedure and was well controlled with intraocular-pressure-lowering medications. Slit lamp examination revealed a moderate anterior chamber inflammation, anterior vitritis, and a large inflammatory membrane attached to the posterior surface of the intraocular implant. A vitrectomy was finally performed in the left eye because of the persistent intermediary inflammation despite the use of high doses of topical and subconjunctival corticosteroids.

Conclusion: Intermediary uveitis is a rare complication after micropulse cyclophotocoagulation diode therapy. To the best of our knowledge, there have been no reports of vitritis after a noncomplicated micropulse cyclophotocoagulation diode in primary open-angle glaucoma.

Keywords: Case report; Glaucoma; Micropulse; Ophthalmology; Vitritis.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no competing interests.

Figures

Fig. 1
Fig. 1
Visual fields. Right eye (RE): 24.2 SITA standard stimulus III. Left eye (LE): 24.2 SITA standard stimulus III
Fig. 2
Fig. 2
Visual fields. Right eye: 24.2 FASTPAC stimulus V. Left eye: 24.2 FASTPAC stimulus V
Fig. 3
Fig. 3
Left eye 7 days after micropulse cyclophotocoagulation diode
Fig. 4
Fig. 4
Left eye 13 days after micropulse cyclophotocoagulation diode
Fig. 5
Fig. 5
Left eye after vitrectomy
Fig. 6
Fig. 6
Timeline of the patient's treatment and medications
See this image and copyright information in PMC

References

    1. Tan AM, Chockalingam M, Aquino MC, Lim ZI, See JL, Chew PT. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol. 2010;38(3):266–272. doi: 10.1111/j.1442-9071.2010.02238.x. - DOI - PubMed
    1. Prager AJ, Anchala AR. Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy. Am J Ophthalmol Case Rep. 2020 doi: 10.1016/j.ajoc.2020.100659. - DOI - PMC - PubMed
    1. IRIDEX (internet). (updated on:-; consulted on 10/11/2020), to consult on: https://iridex.com/MicroPulse.aspx.
    1. Gandolfi S, Marchini G, Caporossi A, et al. Cytidine 5'-diphosphocholine (Citicoline): evidence for a neuroprotective role in glaucoma. Nutrients. 2020;12(3):793. doi: 10.3390/nu12030793. - DOI - PMC - PubMed
    1. Neelakantan A, Vaishnav HD, Iyer SA, Sherwood MB. Is addition of a third or fourth antiglaucoma medication effective? J Glaucoma. 2004;13(2):130–136. doi: 10.1097/00061198-200404000-00008. - DOI - PubMed

Publication types